Notably, while BDNF promoter methylation was not correlated to motor and cognitive clinical symptoms, methylation at the three sites that showed increased levels in HD patients, was inversely correlated to HADS scores, which is a widely used self-report instrument for measuring anxiety and depression in somatically ill patients (Zigmond and Snaith, 1983; Brennan et al., 2010). Here, BDNF is linked to depressive disorder.